Below is information about ALNYLAM HEADQUARTERS from a variety of sources. Please take a look at the materials that our team has selected for you.


Contact Alnylam® Pharmaceuticals

    https://www.alnylam.com/contact-us
    11th Floor of Pacific Century Place Marunouchi 1-11-1 Marunouchi, Chiyoda-ku Tokyo 100-6211 Japan Tel: 0120.970.347

Alnylam Pharmaceuticals Corporate Headquarters, Office ... - Craft

    https://craft.co/alnylam-pharmaceuticals/locations
    Alnylam Pharmaceuticals headquarters and office locations. Alnylam Pharmaceuticals is headquartered in Cambridge, MA and has 7 office locations across 7 countries. ... All Alnylam Pharmaceuticals Locations. Cambridge (HQ), MA. United States. 675 W Kendall St. Paris. France. 100 Av. de Suffren. Milano. Italy. Via Pola, 11. Amsterdam.

Alnylam® Pharmaceuticals

    https://www.alnylam.com/
    Alnylam has led the translation of RNA interference (RNAi) from Nobel Prize-winning discovery into an entirely new class of medicines, which we believe has the potential to help people all over the world to live longer, healthier, and fuller lives. …

Alnylam Pharmaceuticals - Wikipedia

    https://en.wikipedia.org/wiki/Alnylam_Pharmaceuticals
    none

Alnylam Pharmaceuticals Company Profile - Craft

    https://craft.co/alnylam-pharmaceuticals
    Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases. ... Where is Alnylam Pharmaceuticals headquarters? Alnylam Pharmaceuticals headquarters is located at 675 W Kendall St, Cambridge.

Alnylam Pharmaceuticals - Crunchbase Company Profile …

    https://www.crunchbase.com/organization/alnylam-pharmaceuticals
    Contact Email [email protected]. Phone Number 617.551.8200. Alnylam (Nasdaq: ALNY) is the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted …

Alnylam Pharmaceuticals, Inc. Company Profile - Dun

    https://www.dnb.com/business-directory/company-profiles.alnylam_pharmaceuticals_inc.f77aeac5497827e6196179962b069807.html
    Company Description: Like a genetic linebacker, Alnylam Pharmaceuticals runs interference with RNA to prevent the forward progress of disease. RNA interference (RNAi) technology developed by the biotech firm can selectively shut off harmful genes. The company is developing a pipeline of candidates both individually and through collaborations with other drugmakers.

Alnylam’s Manufacturing Facility, Norton, Massachusetts

    https://www.pharmaceutical-technology.com/projects/alnylams-manufacturing-facility-norton-massachusetts/
    Alnylam Pharmaceuticals is constructing a new drug substance manufacturing and cGMP warehouse facility in Norton, Massachusetts, US. The company broke ground on the $200m facility in April 2016. ... The proximity of the facility to its …

Alnylam (ALNY) Stock Information | Alnylam Pharmaceuticals

    https://investors.alnylam.com/alny-stock-information
    Alnylam trades on the NASDAQ Stock Market under the symbol ALNY. container. container-970 mb-65 stock-chart. ALNY Chart by TradingView. grey-bg padding-top-bottom-65. container. container-970 d-flex flex-1.

Preclinical Results on Alnylam’s Novel C16 Conjugate Technology …

    https://capella.alnylam.com/2022/05/11/tides-2022
    New results on Alnylam’s platform advancements enabling delivery of therapeutic short interfering RNAs (siRNAs) to the central nervous system (CNS) were presented at the TIDES USA, Oligonucleotide & Peptide Therapeutics 2022 Meeting being held in Boston on May 9-12. Additional preclinical data were presented on...

Did you find the information you need about ALNYLAM HEADQUARTERS?

We hope you found all the information about ALNYLAM HEADQUARTERS you were looking for and more.